Irene T. Weber - Search Results

Year	Number of Results
2002	5
2003	4
2004	6
2005	3
2006	10
2007	11
2008	12
2009	7
2010	7
2011	5
2012	8
2013	6
2014	6
2015	10
2016	7
2017	6
2018	7
2019	5
2020	6
2021	5
2022	2

1

HIV Protease: Historical Perspective and Current Research.

Weber IT, Wang YF, Harrison RW. Weber IT, et al. Viruses. 2021 May 6;13(5):839. doi: 10.3390/v13050839. Viruses. 2021. PMID: 34066370 Free PMC article. Review.

2

Decoding HIV resistance: from genotype to therapy.

Weber IT, Harrison RW. Weber IT, et al. Future Med Chem. 2017 Sep;9(13):1529-1538. doi: 10.4155/fmc-2017-0048. Epub 2017 Aug 9. Future Med Chem. 2017. PMID: 28791894 Free PMC article. Review.

3

Tackling the problem of HIV drug resistance.

Weber IT, Harrison RW. Weber IT, et al. Postepy Biochem. 2016;62(3):273-279. Postepy Biochem. 2016. PMID: 28132481 Free article. Review. English.

4

Highly resistant HIV-1 proteases and strategies for their inhibition.

Weber IT, Kneller DW, Wong-Sam A. Weber IT, et al. Future Med Chem. 2015;7(8):1023-38. doi: 10.4155/fmc.15.44. Future Med Chem. 2015. PMID: 26062399 Free PMC article. Review.

5

Reaction intermediates discovered in crystal structures of enzymes.

Weber IT, Agniswamy J, Fu G, Shen CH, Harrison RW. Weber IT, et al. Adv Protein Chem Struct Biol. 2012;87:57-86. doi: 10.1016/B978-0-12-398312-1.00003-2. Adv Protein Chem Struct Biol. 2012. PMID: 22607752 Review.

6

HIV-1 protease: structure, dynamics, and inhibition.

Louis JM, Ishima R, Torchia DA, Weber IT. Louis JM, et al. Among authors: weber it. Adv Pharmacol. 2007;55:261-98. doi: 10.1016/S1054-3589(07)55008-8. Adv Pharmacol. 2007. PMID: 17586318 Review. No abstract available.

7

Evolution of drug resistance in HIV protease.

Shah D, Freas C, Weber IT, Harrison RW. Shah D, et al. Among authors: weber it. BMC Bioinformatics. 2020 Dec 30;21(Suppl 18):497. doi: 10.1186/s12859-020-03825-7. BMC Bioinformatics. 2020. PMID: 33375936 Free PMC article.

8

Analysis of drug resistance in HIV protease.

Pawar SD, Freas C, Weber IT, Harrison RW. Pawar SD, et al. Among authors: weber it. BMC Bioinformatics. 2018 Oct 22;19(Suppl 11):362. doi: 10.1186/s12859-018-2331-y. BMC Bioinformatics. 2018. PMID: 30343664 Free PMC article.

9

Revertant mutation V48G alters conformational dynamics of highly drug resistant HIV protease PRS17.

Burnaman SH, Kneller DW, Wang YF, Kovalevsky A, Weber IT. Burnaman SH, et al. Among authors: weber it. J Mol Graph Model. 2021 Nov;108:108005. doi: 10.1016/j.jmgm.2021.108005. Epub 2021 Aug 11. J Mol Graph Model. 2021. PMID: 34419931

10

Drug targets in human T-lymphotropic virus type 1 (HTLV-1) infection.

Boross P, Bagossi P, Weber IT, Tözsér J. Boross P, et al. Among authors: weber it. Infect Disord Drug Targets. 2009 Apr;9(2):159-71. doi: 10.2174/187152609787847686. Infect Disord Drug Targets. 2009. PMID: 19275704 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results